Cargando…

Targeted Metabolomics Identifies Plasma Biomarkers in Mice with Metabolically Heterogeneous Melanoma Xenografts

SIMPLE SUMMARY: Studying the metabolome, the complete set of metabolites found in a biological sample, helps to understand how metabolism differs between healthy and diseased individuals. Malignant skin cancers (melanomas) differ greatly in their mutational landscapes and metabolism among individual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weber, Daniela D., Thapa, Maheshwor, Aminzadeh-Gohari, Sepideh, Redtenbacher, Anna-Sophia, Catalano, Luca, Feichtinger, René G., Koelblinger, Peter, Dallmann, Guido, Emberger, Michael, Kofler, Barbara, Lang, Roland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865782/ https://www.ncbi.nlm.nih.gov/pubmed/33498757 http://dx.doi.org/10.3390/cancers13030434

Ejemplares similares

Ketogenic diets slow melanoma growth in vivo regardless of tumor genetics and metabolic plasticity
por: Weber, Daniela D., et al.
Publicado: (2022)

Targeting Mitochondria in Melanoma
por: Aminzadeh-Gohari, Sepideh, et al.
Publicado: (2020)

Untargeted Metabolomics Reveals Molecular Effects of Ketogenic Diet on Healthy and Tumor Xenograft Mouse Models
por: Licha, David, et al.
Publicado: (2019)

From old to new — Repurposing drugs to target mitochondrial energy metabolism in cancer
por: Aminzadeh-Gohari, Sepideh, et al.
Publicado: (2020)

Ketogenic diet in the treatment of cancer – Where do we stand?
por: Weber, Daniela D., et al.
Publicado: (2019)

Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts
por: Catalano, Luca, et al.
Publicado: (2023)

A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model
por: Aminzadeh-Gohari, Sepideh, et al.
Publicado: (2017)

Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model
por: Morscher, Raphael Johannes, et al.
Publicado: (2016)

Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model
por: Morscher, Raphael Johannes, et al.
Publicado: (2015)

Lithium and Not Acetoacetate Influences the Growth of Cells Treated with Lithium Acetoacetate
por: Vidali, Silvia, et al.
Publicado: (2019)

Metabolic reprogramming related to whole-chromosome instability in models for Hürthle cell carcinoma
por: Addie, Ruben D., et al.
Publicado: (2020)

The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome
por: Vidali, Silvia, et al.
Publicado: (2017)

The role of cyclin D1 and Ki‐67 in the development and prognostication of thin melanoma
por: Kaufmann, Corina, et al.
Publicado: (2020)

Trackable and scalable LC-MS metabolomics data processing using asari
por: Li, Shuzhao, et al.
Publicado: (2023)

Ketogenic diet in cancer therapy
por: Weber, Daniela D., et al.
Publicado: (2018)

COVID-19-Induced Reduction in Primary Melanoma Diagnoses: Experience from a Dermatopathology Referral Center
por: Hoellwerth, Magdalena, et al.
Publicado: (2021)

Temporal heterogeneity in oxygen tension in human melanoma xenografts
por: Brurberg, K G, et al.
Publicado: (2003)

Targeting L-Lactate Metabolism to Overcome Resistance to Immune Therapy of Melanoma and Other Tumor Entities
por: Feichtinger, René G., et al.
Publicado: (2019)

Verteporfin-induced proteotoxicity impairs cell homeostasis and survival in neuroblastoma subtypes independent of YAP/TAZ expression
por: Condurat, Alexandra-Larisa, et al.
Publicado: (2023)

Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts
por: Graff, B A, et al.
Publicado: (2003)

Targeted treatment of advanced NRAS-mutated melanoma
por: Koelblinger, Peter, et al.
Publicado: (2017)

Peculiarities and pitfalls of quantifying mitochondrial energy metabolism in the skin
por: Feichtinger, René G., et al.
Publicado: (2016)

A pilot metabolomic study of drug interaction with the immune response to seasonal influenza vaccination
por: Siddiqa, Amnah, et al.
Publicado: (2023)

Revisiting the Role of the CXCL13/CXCR5-Associated Immune Axis in Melanoma: Potential Implications for Anti-PD-1-Related Biomarker Research
por: Hoellwerth, Magdalena, et al.
Publicado: (2023)

Development of encorafenib for BRAF-mutated advanced melanoma
por: Koelblinger, Peter, et al.
Publicado: (2018)

Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts
por: Kemper, Kristel, et al.
Publicado: (2015)

Transient perfusion in human melanoma xenografts.
por: Tufto, I., et al.
Publicado: (1995)

New developments in the treatment of basal cell carcinoma: update on current and emerging treatment options with a focus on vismodegib
por: Koelblinger, Peter, et al.
Publicado: (2018)

Comparative effects of systemic administration of levofloxacin and cephalexin on fracture healing in rats
por: Golestani, Shayan, et al.
Publicado: (2022)

In vitro chemosensitivity tests on xenografted human melanomas.
por: Bateman, A. E., et al.
Publicado: (1980)

Role of Hydrogen Sulfide in Inflammatory Bowel Disease
por: Stummer, Nathalie, et al.
Publicado: (2023)

Application of spectroscopy in herbal metabolomics
por: Saeidnia, Soodabeh, et al.
Publicado: (2012)

Heterogeneity in Melanoma
por: Ng, Mei Fong, et al.
Publicado: (2022)

Vascular abnormalities and development of hypoxia in microscopic melanoma xenografts
por: Gaustad, Jon-Vidar, et al.
Publicado: (2017)

Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma †
por: Hoffman, Robert M.
Publicado: (2017)

Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
por: Ressler, Julia Maria, et al.
Publicado: (2021)

No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis
por: Bluemlein, Katharina, et al.
Publicado: (2011)

Reduced Levels of ATP Synthase Subunit ATP5F1A Correlate with Earlier-Onset Prostate Cancer
por: Feichtinger, René G., et al.
Publicado: (2018)

Low VDAC1 Expression Is Associated with an Aggressive Phenotype and Reduced Overall Patient Survival in Cholangiocellular Carcinoma
por: Feichtinger, René Günther, et al.
Publicado: (2019)

Lack of Efficacy of Combined Antiangiogenic Therapies in Xenografted Human Melanoma
por: Adamcic, Una, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_r0vgdf1hr44gat1v4eap842j5f